AGP Executive Report
Last update: an hour agoDrug Approvals & Antimicrobial Resistance: Wockhardt’s ZAYNICH (cefepime + zidebactam) got FDA approval for complicated UTIs, including acute pyelonephritis, targeting susceptible Gram-negative pathogens. Oncology Breakthrough: Akeso’s ivonescimab cut the risk of death by 34% in a phase 3 trial for advanced squamous NSCLC, earning ASCO plenary selection—an important win for China-originated oncology. Public Health Policy Debate: WHO’s first nicotine pouch report faces pushback from harm-reduction advocates, who say it downplays pouch safety versus smoking. Wellness & Healthy Ageing: India’s Ayush set “Yoga for Healthy Ageing” as the theme for International Day of Yoga 2026, as yoga use expands alongside longevity concerns. Healthcare Workforce & Access: A study flags looming cancer workforce shortages by 2050, with nurses and diagnostic specialists among the hardest-hit roles. Ebola Response: China says it’s sending emergency medical teams and aid to Ebola-hit DRC as cases spread. Regional Health Security: U.S. CDC is partnering with India on AI tools to speed up antimicrobial resistance detection and response. Care for Families: Cordlife India’s “Save The Sibling” initiative highlights cord-blood banking and stem-cell matching for severe thalassemia cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
